Christopher J. Long, MD

Christopher J. Long, MD, is a pediatric urology fellow in the Division of Urology at The Children's Hospital of Philadelphia.

Areas of Expertise: Hypospadias, Minimally invasive surgery, Pediatric urologic oncology, Stone disease
Locations: Main Campus
Phone: 215-590-2754

  • Education and Training

    Medical School

    MD - University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, NJ

    Internship

    General Surgery - Temple University Hospital, Philadelphia PA

    Residency

    General Surgery - Temple University Hospital, Philadelphia, PA
    Urology - Temple University Hospital, Philadelphia, PA

    Fellowship

    Pediatric Urology - The Children's Hospital of Philadelphia, Philadelphia, PA

  • Titles and Academic Titles

    Urology Fellow

  • Centers and Programs
  • Research Interests

    Bladder remodeling
    Impact of social stress upon voiding phenotype

  • Publications

    Papers

    Zaontz, MR, Long CJ. “Management of Distal Hypospadias.” AUA Update Series 2013.

    Long CJ, Canter DJ, Smaldone MC, Simhan J, Rozenfeld B, Teper E, Chen DYT, Greenberg RE, Viterbo R, Uzzo RG, Kutikov A. “Role of Tumor Location in Selecting Patients for Percutaneous Versus Surgical Cryoablation of Renal Masses.” Can J Urol 2012 Oct; 19(5):6417-22.

    Long CJ, Canter DJ, Kutikov A, Li T, Simhan J, Smaldone M, Teper E, Viterbo R, Boorjian SA, Chen DY, Greenberg RE, Uzzo RG. “Partial Nephrectomy for Renal Masses ≥ 7cm: technical, oncological, and functional outcomes.” BJU Int 2012 May;109(10)1450-6.

    Dean GE, Long CJ. “Updates in the Management of the Overactive Bladder in Patients with Myelomeningocele.” Curr Urol Rep 2011 Dec ; 12(6):413

    Long CJ, Kutikov A, Canter DJ, Egleston BL, Chen DYT, Viterbo R, Boorjian S, Uzzo R. “Percutaneous versus surgical cryoablation of the small renal mass: is efficacy
    compromised?” BJU Int. 2011 May;107(9):1376.

    Makhlin I, Zhang J, Long CJ, Devarajan K, Zhou Y, Klein-Szanto AJ, Huang M, CHernoff J, Boorjian SA. “The mTOR pathway affects proliferation and chemosensitivity of urothelial carcinoma cells and is upregulated in a subset of human bladder cancers.” BJU Int. 2011 Jul;108(2 Pt 2):E84

    Canter D, Long C, Kutikov A, Plimack E, Saad I, Oblaczynski M, Zhu F, Viterbo R, Chen DY, Uzzo RG, Greenberg RE, Boorjian SA. “Clinicopathological outcomes after radical cystectomy for T2 urothelial carcinoma: further evidence to support the use of neoadjuvant chemotherapy.” BJU Int. 2011 Jan; 107(1):58

    Posters and Presentations

    “Nuclear Factor of Activated T-cells (NFAT) c4 Gene Deletion Confers Resistance to Social Stress Induced Voiding Dysfunction.”
    • Long CJ*, Frank C, Butler S, Canning D, Valentino R, Zderic SA
    • American Urological Association Annual Meeting, San Diego; May 2013

    “Nuclear Factor of Activated T-cells (NFAT) c4 Gene Deletion Confers Resistance to Social Stress Induced Voiding Dysfunction.”
    • Long CJ*, Frank C, Butler S, Canning D, Valentino R, Zderic SA
    • European Society for Pediatric Urology, Genoa, Italy April 2013

    “Partial Nephrectomy for Renal Masses ≥ 7cm is Technically Feasible, Oncologically sound, and Preserves Renal Function.”
    • Long CJ, Canter DJ, Cronson BA*, Kutikov A, Li T, Viterbo R, Chen D, Greenberg RE, Uzzo RG
    • American Urological Association Annual Meeting, Atlanta; May 2012

    “Role of Tumor Location and Provider Specialty In Selecting Patients for Percutaneous vs Surgical Cryoablation of the Small Renal Mass.”
    • Jani SD, Long CJ, Canter DJ, SMaldone MC, Teper E, Chen DYT, Viterbo R, Greenberg RE, Uzzo RG, Kutikov A
    • Philadelphia Urologic Society, Resident competition; March 2011